Ipsen News
Most Popular Ipsen Story
Ipsen hands back Parkinson's drug rights to Santhera
French drugmaker Ipsen ($IPN) has a game plan for developing new drugs, and Santhera's ($SANN) Parkinson's disease treatment fipamezole didn't make the cut. Switzerland-based Santhera said that it Read more...
Latest Headlines
- January 24, 2012
- December 15, 2011
- November 23, 2011
- October 3, 2011
- March 2, 2011
- October 21, 2010
- September 13, 2010
- September 3, 2010
- March 23, 2010
- January 21, 2010
- June 17, 2009
- June 6, 2008
- June 5, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
